Search results

Autism spectrum conditions (ASC) and borderline personality disorder (BPD) have overlapping symptom profiles. Dialectical behaviour therapy (DBT) is an established treatment for self-harm and BPD, but little research has investigated the outcomes of DBT for ASC populations. This exploratory service evaluation aims to investigate the outcomes of a comprehensive DBT programme for adolescents with a diagnosis of emerging BPD and a co-occurring ASC diagnosis as compared to those without an ASC diagnosis.

Differences from the start to end of treatment in the frequency of self-harming behaviours, BPD symptoms, emotion dysregulation, depression, anxiety, the number of A&E attendances and inpatient bed days, education and work status, and treatment non-completion rates were analysed for those with an ASC diagnosis, and compared between those with an ASC diagnosis and those without.

Significant medium to large reductions in self-harming behaviours, BPD symptoms, emotion dysregulation and inpatient bed days were found for those with an ASC diagnosis by the end of treatment. There were no significant differences between those with an ASC and those without in any outcome or in non-completion rates. These findings indicate that DBT may be a useful treatment model for those with an ASC diagnosis, though all results are preliminary and require replication.

To the best of the authors’ knowledge, this is the first study to report the outcomes of a comprehensive DBT programme for adolescents with an ASC diagnosis, and to compare the changes in outcomes between those with a diagnosis and those without.

The purpose of this paper is to compare beliefs about medication prescribed for bipolar disorder across professional groups within Community Mental Health Teams (CMHTs) – psychiatric nurses, psychiatrists, support workers, social workers, and occupational therapists – who each receive different training.

Participants (n=138) completed an adapted version of the Beliefs about Medicines Questionnaire. ANOVAs with Tukey's post hoc tests were used to compare beliefs across professional groups.

Beliefs about medication differed across professional groups, with psychiatrists believing most strongly that medication is necessary in the treatment of bipolar disorder (p<0.05) and reporting the lowest concern about its adverse effects (p<0.05). Psychiatrists and social workers were significantly more likely to believe that patients take less than instructed than occupational therapists, nurses and support workers (p<0.05).

The differences in perceptions of medication across professional groups may reflect differences in training, with the role of medication traditionally being “downplayed” on some training courses. This has implications for patient adherence, as patients' beliefs about medication are likely to be influenced by those of their key workers. This is particularly relevant in terms of “New Ways of Working” where patients are likely to see psychiatrists less often.

This original research provides evidence to support the provision of training about medications and adherence in bipolar disorder for CMHT workers, who may not have had exposure to such training as part of their primary qualification.